Tyloxapol Production Cost Reports

The report provides a detailed analysis essential for establishing a tyloxapol production plant. It encompasses all critical aspects necessary for tyloxapol production, including the cost of tyloxapol production, tyloxapol plant cost, tyloxapol production costs, and the overall tyloxapol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a tyloxapol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tyloxapol is a non-ionic surfactant and pharmaceutical excipient that is used to liquefy and clear thick mucus and pus from the lungs. It is inhaled via nebuliser or oxygen stream and aids conditions like bronchopulmonary infections, cystic fibrosis, and chronic respiratory diseases. It is utilised in drug formulations as an emulsifier and stabiliser in oral liquids, suspensions, inhalation products, topical preparations, and oil-in-water systems.

It improves ingredient blending, solubility, and bioavailability of active drugs. It is also utilised in advanced delivery like niosomes for sustained release of antiretrovirals or anti-tuberculosis agents. Its common side effects include mild irritation to the eyes, skin, and respiratory tract upon contact or inhalation.

The market for tyloxapol is driven by its usage as a specialised USP-grade non-ionic surfactant. Its growing demand among pharmaceutical manufacturers that need good quality emulsifiers and stabilisers for complex formulations contributes to its market demand. Its utilisation in ophthalmic solutions and inhalation aerosols used in respiratory conditions like cystic fibrosis, chronic bronchitis, and bronchopulmonary infections boosts its market.

 The oral suspensions, topical creams, and experimental advanced delivery systems like niosomes make it a popular product. The industrial tyloxapol procurement is affected by the need for high-purity grades for inhalation and ocular safety. The instability in the price of petrochemical-derived raw material and the strict FDA requirements that require verified stability and low toxicity profiles impact its sourcing.

Raw Material for Tyloxapol Production

According to the tyloxapol production plant project report, the key raw materials used in the production of tyloxapol include p tert octylphenol and formaldehyde.

Production Process of Tyloxapol

The extensive tyloxapol production cost report consists of the following major industrial production process:

1. From p tert octylphenol and formaldehyde: The production process of tyloxapol involves three stages that start from p tert octylphenol. First, p tert octylphenol is reacted with formaldehyde in the presence of an inorganic base to form a bis methylol derivative. Then this bis methylol intermediate is condensed with more p tert octylphenol under acidic conditions to build a phenolic resin. Finally, the phenolic resin is ethoxylated with ethylene oxide under typical oxyethylation conditions to introduce polyoxyethylene chains, giving tyloxapol as the final product.

Tyloxapol is a polymeric non-ionic surfactant with an average formula of (C14H22O.C2H4O.CH2O)n, where n ≈ 6-8. Its molecular weight is around 280.41 g/mol per repeating unit (polydisperse 6,000-10,000 Da range). It appears as a clear to hazy yellow-amber viscous liquid which is freely miscible in water. It is also soluble in chloroform, DMSO, methanol, benzene, toluene, acetic acid, and miscible with ethanol and acetone. It has a flash point of 113  degree Celsius with micelle concentration of 0.018 mM and high microviscosity micelles forming small spherical structures ~3.5 nm radius. It requires storage under inert gas at 2-8  degree Celsius because of its sensitivity. It has a hydrophobic alkylphenol core and hydrophilic ethylene oxide tails, enabling emulsification, low foaming, and wetting.